image
REGENXBIO Inc. RGNX
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 8.43
-1.63 %
$ 425 M
Market Cap
-2.73
P/E
Price Target Average
215.54%
Revenue Forecast Estimate
71.86%
EBIT Estimate
--20.12%
Net Income Estimate
26.13%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets REGENXBIO Inc.
image
Wall Street analysts predict an average 1-year price target for RGNX of $26.6 , with forecasts ranging from a low of $18 to a high of $39 .
RGNX Lowest Price Target Wall Street Target
18 USD 113.52%
RGNX Average Price Target Wall Street Target
26.6 USD 215.54%
RGNX Highest Price Target Wall Street Target
39 USD 362.63%
Price
Max Price Target
Min Price Target
Average Price Target
404035353030252520201515101055Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart RGNX

image
$800.0m$800.0m$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart RGNX

image
$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart RGNX

image
$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)201520152016201620172017201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029